How much does a box of ponatinib cost? Summary of market prices and drug purchase information for reference in pharmacies in various regions

Ponatinib (Ponatinib) is an oral third-generation tyrosine kinase inhibitor (TKI), mainly used to treat patients with imatinib, dasatinib or nivolumab. Patients with lotinib-resistant chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). Ponatinib has only been on the market for a short time in China, so the price information and medical insurance reimbursement policies in domestic pharmacies are unclear. If domestic patients need to use ponatinib, they usually need to obtain it through regular overseas channels or imported drugs.

In overseas markets, the original drug of ponatinib is mainly represented by the Hong Kong version, which sells for about more than 17,000 yuan per box. The original drug has complete drug registration and clinical data support, and its efficacy and safety have been strictly verified, making it suitable for patients who need reliable treatment guarantees. However, due to the higher price, the financial burden is greater for patients with long-term treatment or self-pay.

In addition, a number of generic drugs have been launched in overseas markets. Taking the Lao version and the Bangladeshi version as examples, each box of the Lao version of the generic medicine sells for about more than 700 yuan, while the Bangladeshi version of the generic medicine sells for about more than 1,000 yuan per box. These generic drugs are basically the same as the original drugs in terms of ingredients and efficacy, but are more affordable, providing a viable treatment option for patients who cannot afford the high-priced original drugs.

In terms of drug purchase channels, both overseas generic drugs and original drugs must be purchased through regular drug suppliers or certified overseas pharmacies to ensure drug quality and safety. During use, patients should strictly follow the doctor's prescription and medication plan, regularly review blood indicators and cardiovascular function, and avoid changing the dosage or drug source on their own. By rationally selecting drug versions and scientifically managing treatment plans, patients can control medication costs while ensuring efficacy.

Reference materials:https://www.drugs.com/